Authors
Loading...
Indoramin reduces 24-h ambulatory BP; Level 3 trial leaves open its role versus established agents.
Key points are not available for this paper at this time.
Gould et al. (1981) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: